Stockreport

MPOX is Emerging as a Global Threat - NanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX [Yahoo! Finance]

NanoViricides, Inc.  (NNVC) 
NASDAQ:AMEX Investor Relations: nanoviricides.com/investorinfo.html
PDF antiviral nanomedicines, reports today that it is investigating the possibility of using NV-387 for the treatment of MPOX patients under the WHO MEURI protocol, in light [Read more]